NSE filing, NSE: KREBSBIO. Summary written from the filing by ALFA Finder's alert engine.
Krebs Biochemicals & Industries Ltd: key numbers
- Share price
- ₹56.60
- Market cap
- ₹122.0 Cr
- Revenue (annual)
- ₹23.73 Cr
- Net profit (annual)
- ₹-16.93 Cr
- P/E (TTM)
- -9.1×Sector 45.9×
- Promoter holding
- 72.74%+0.00% QoQ
- FII holding
- 0.50%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Krebs Biochemicals & Industries Ltd
All →Krebs Biochemicals & Industries Q2 FY27 Results: Net Loss of ₹5.4 Cr, Loss Narrows
Krebs Biochemicals reported Q2 FY27 standalone results with a net loss of Rs.539.85 Cr. The half-year loss widened to Rs.788.33 Cr amid Vizag unit closure.
- Key figure
- Net loss ₹5.4 Cr
Krebs Biochemicals & Industries Board Meeting Date
Krebs Biochemicals & Industries Limited has scheduled a board meeting for October 29, 2026. The board will consider and adopt unaudited financial results for the second quarter.
Krebs Biochemicals & Industries Other Announcement
Krebs Biochemicals & Industries Ltd filed its quarterly shareholding pattern as mandated by SEBI regulations, disclosing the distribution of equity stakes among shareholders.
Krebs Biochemicals & Industries Annual General Meeting
Krebs Biochemicals & Industries Limited conducted its 34th Annual General Meeting on September 29, 2026. Shareholders considered the adoption of FY2025-26 audited financials and related party transactions.
Krebs Biochemicals & Industries Annual General Meeting
Krebs Biochemicals and Industries Limited has issued a notice for its 34th Annual General Meeting scheduled for September 29, 2026. Key agenda items include the approval of financial statements and related party transactions.
Krebs Biochemicals & Industries Annual Report
Krebs Biochemicals & Industries Limited has submitted its 34th Annual Report for the financial year 2025-26. The report includes financial highlights, directors' report, and audited financial statements.
Other price movement clarification announcements
All →Olatech Solutions Price Movement Clarification
Olatech Solutions said its share price movement was purely market driven, responding to a BSE query. It stated it remains compliant with Regulation 30 disclosures.
Black Opal Consultants Price Movement Clarification
Black Opal Consultants clarified to BSE on recent share price movement. It says no pending price-sensitive information exists and the move appears market-driven.
SJP Ultrasonics Price Movement Clarification
SJP Ultrasonics clarified to BSE that it is unaware of any undisclosed price-sensitive information behind a recent significant share price movement. It cannot comment on the causes, which it attributes to market factors.
Filtron Engineers Price Movement Clarification
Filtron Engineers says its recent share price movement is market-driven and no price-sensitive information is pending. It replies to a BSE query dated 29 October 2026.
Century Business Media Price Movement Clarification
Century Business Media is unaware of any reason for its recent share price movement. It attributes the move to market conditions.
Suzlon Energy Price Movement Clarification
Suzlon Energy reported a material price movement on 30 Oct 2026. The company stated no identifiable event or media report triggered the move.